**The previous Hot Corner email contained the incorrect day's post. Today's correct Hot Corner report is below. Apologies for the confusion.
Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.
📌 Celcuity $CELC — Baker Bros. Advisors increased its 13D stake from 17.11% to 19.99%.
The biotech-focused specialists continue to press their bet, adding on strength and pushing ownership close to 20%.
When the Baker Bros lean in like this, it's worth paying attention.
📌 ARS Pharmaceuticals $SPRY — Millennium Management increased its 13G stake from 3.21% to 5.40%.
The multi-strategy fund crosses the key 5% threshold, building a meaningful position in the biotech name as shares continue to carve out a multi-year distribution range.
Here's The Hot Corner, with data from March 24, 2026: